[弥漫性自主性甲状腺肿伴突眼性甲状腺肿患者甲状腺功能亢进症的抗甲状腺治疗结果]
[Results of thyrostatic therapy of hyperthyroidism in patients with Basedow's disease and disseminated autonomy].
作者信息
Meng W, Meng S, Hampel R, Ventz M, Männchen E, Weber W, Streckenbach B
机构信息
Abteilung für Endokrinologie und Stoffwechselkrankheiten Klinik für Innere Medizin Ernst-Moritz-Arndt-Universität Greifswald.
出版信息
Dtsch Z Verdau Stoffwechselkr. 1987;47(6):337-40.
Up to now the results of drug treatment are unsatisfying. Treatment of more than 1-2 years did not decrease the occurrence of relapses. Thyroid suppression test and TRH test give the same indications concerning the outcome in cases with Graves' disease and disseminated autonomy (short-time prognosis). The relapse rate is distinctly higher in Graves' disease than in cases with disseminated autonomy (goitre class 3 excluded).
到目前为止，药物治疗的结果并不令人满意。超过1 - 2年的治疗并未降低复发率。甲状腺抑制试验和促甲状腺激素释放激素试验在格雷夫斯病和弥漫性自主性疾病（短期预后）的病例中给出了相同的关于预后的指征。格雷夫斯病的复发率明显高于弥漫性自主性疾病（不包括3级甲状腺肿）的病例。
Zotero 插件